Windtree Therapeutics logo

Windtree Therapeutics Share Price Today

(NASDAQ: WINT)

Windtree Therapeutics share price is $1.86 & ₹161.76 as on 6 Mar 2025, 2.30 'hrs' IST

$1.86

-0.39

(-17.33%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Windtree Therapeutics share price in Dollar and Rupees. Guide to invest in Windtree Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Windtree Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Windtree Therapeutics share price movements

  • Today's Low: $1.81
    Today's High: $2.28

    Day's Volatility :20.61%

  • 52 Weeks Low: $1.81
    52 Weeks High: $737.44

    52 Weeks Volatility :99.75%

Windtree Therapeutics (WINT) Returns

PeriodWindtree Therapeutics IncIndex (Russel 2000)
3 Months
-90.42%
0.0%
6 Months
-98.79%
0.0%
1 Year
-99.48%
0.0%
3 Years
-100.0%
-11.6%

Windtree Therapeutics (WINT) Key Statistics

in dollars & INR

Previous Close
$2.25
Open
$2.24
Today's High
$2.28
Today's Low
$1.8101
Market Capitalization
$4.9M
Today's Volume
$464.1K
52 Week High
$737.435
52 Week Low
$1.81
Revenue TTM
$0.0
EBITDA
$-24.7M
Earnings Per Share (EPS)
$-19.03
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-150.8%

How to invest in Windtree Therapeutics Stock (WINT) from India?

It is very easy for Indian residents to invest directly in Windtree Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Windtree Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Windtree Therapeutics or WINT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Windtree Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Windtree Therapeutics shares which would translate to 0.468 fractional shares of Windtree Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Windtree Therapeutics, in just a few clicks!

Returns in Windtree Therapeutics (WINT) for Indian investors in Rupees

The Windtree Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Windtree Therapeutics investment value today

Current value as on today

₹5,468

Returns

₹94,532

(-94.53%)

Returns from Windtree Therapeutics Stock

₹99,481 (-99.48%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Windtree Therapeutics (WINT)

49%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Windtree Therapeutics Stock from India on INDmoney has increased by 49% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Windtree Therapeutics

  • Renaissance Technologies Corp

    0.32%

  • UBS Group AG

    0.16%

  • Geode Capital Management, LLC

    0.16%

  • XTX Topco Ltd

    0.05%

  • Two Sigma Investments LLC

    0.04%

  • Cubist Systematic Strategies, LLC

    0.04%

Analyst Recommendation on Windtree Therapeutics

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Windtree Therapeutics(by analysts ranked 0 to 5 stars)

Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
3
3
3
Sell
3
3
3

Analyst Forecast on Windtree Therapeutics Stock (WINT)

What analysts predicted

Upside of 276.34%

Target:

$7.00

Current:

$1.86

Insights on Windtree Therapeutics Stock (Ticker Symbol: WINT)

  • Price Movement

    In the last 7 days, WINT stock has moved down by -45.9%
  • WINT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 166.0%
  • WINT vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 151.6%

Windtree Therapeutics Technicals Summary

Sell

Neutral

Buy

Windtree Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Windtree Therapeutics (WINT) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Windtree Therapeutics Inc logo
-68.9%
-98.79%
-99.48%
-100.0%
-100.0%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Windtree Therapeutics Inc logo
0.83
NA
0.0
-2.38
-1.51
-0.45
NA
5.9
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Windtree Therapeutics Inc logo
Sell
$4.9M
-100.0%
0.83
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Windtree Therapeutics

Windtree Therapeutics, Inc., a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. The company's lead product candidate is istaroxime, which is in Phase 2b clinical trial for the treatment of acute decompensated heart failure, as well as for the treatment of early cardiogenic shock. It also develops AEROSURF, an aerosolized KL4 surfactant that is in Phase 2b clinical trial to treat respiratory distress syndrome in premature infants; Surfaxin, a lyophilized KL4 surfactant, which is in Phase 2a clinical trial for the treatment of lung injury resulting from COVID-19; Rostafuroxin that is in Phase 2b clinical trial for the treatment of genetically associated hypertension; and oral and intravenous SERCA2a activator, which is in preclinical trial for the treatment of chronic and acute heart failure. In addition, it is developing aPKCi Inhibitor for the treatment of cutaneous malignancies and solid tumors that is in preclinical trials. Windtree Therapeutics, Inc. has a collaboration with Universita degli Studi di Milano-Bicocca for the discovery and development of new SERCA2a compounds for the treatment of chronic and acute human heart failure; a strategic alliance with Laboratorios del Dr. Esteve, S.A. for the development, marketing, and sale of a portfolio of potential KL4 surfactant products; license, development and commercialization agreement with Lee's Pharmaceutical (HK) Ltd. and Zhaoke Pharmaceutical (Hefei) Co. Ltd.; license agreement with Philip Morris USA, Inc. and Johnson & Johnson; and collaboration with Battelle Memorial Institute for development of its ADS for use in its phase III program. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. The company was founded in 1992 and is headquartered in Warrington, Pennsylvania.
Organization
Windtree Therapeutics
Employees
0
CEO
Mr. Jed A. Latkin
Industry
Biotechnology

Management People of Windtree Therapeutics

NameTitle
Mr. Jed A. Latkin
CEO & Director
Mr. Eric L. Curtis M.B.A.
President & COO
Dr. Steven G. Simonson M.D., M.H.S
Senior VP & Chief Medical Officer
Ms. Jamie McAndrew
Senior VP, CFO, Chief Accounting Officer, Controller & Corporate Secretary
Mr. George Cox
Vice President of Technical Operations
Dr. Pratap Paruchuru
Executive Director of Clinical Development
Ms. Tracy Rarick
Head of Operations & Program Management

Important FAQs about investing in WINT Stock from India :

What is Windtree Therapeutics share price today?

Windtree Therapeutics share price today stands at $1.86, Open: $2.24 ; Previous Close: $2.25 ; High: $2.28 ; Low: $1.81 ; 52 Week High: $737.44 ; 52 Week Low: $1.81.

The stock opens at $2.24, after a previous close of $2.25. The stock reached a daily high of $2.28 and a low of $1.81, with a 52-week high of $737.44 and a 52-week low of $1.81.

Can Indians buy Windtree Therapeutics shares?

Yes, Indians can invest in the Windtree Therapeutics (WINT) from India.

With INDmoney, you can buy Windtree Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Windtree Therapeutics at zero transaction cost.

How can I buy Windtree Therapeutics shares from India?

It is very easy to buy Windtree Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Windtree Therapeutics (WINT) be purchased?

Yes, you can buy fractional shares of Windtree Therapeutics with INDmoney app.

What are the documents required to start investing in Windtree Therapeutics stocks?

To start investing in Windtree Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Windtree Therapeutics Stock (WINT)?

Today’s highest price of Windtree Therapeutics (WINT) is $2.28.

Today’s lowest price of Windtree Therapeutics (WINT) is $1.81.

What is today's market capitalisation of Windtree Therapeutics?

Today's market capitalisation of Windtree Therapeutics WINT is 4.9M

What is the 52 Week High and Low Range of Windtree Therapeutics Stock (WINT)?

  • 52 Week High

    $737.44

  • 52 Week Low

    $1.81

What are the historical returns of Windtree Therapeutics (WINT)?

  • 1 Month Returns

    -68.9%

  • 3 Months Returns

    -98.79%

  • 1 Year Returns

    -99.48%

  • 5 Years Returns

    -100%

Who is the Chief Executive Officer (CEO) of Windtree Therapeutics ?

Mr. Jed A. Latkin is the current Chief Executive Officer (CEO) of Windtree Therapeutics.